Helius Medical Technologies, Inc. (HSDT )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol HSDT
- Company Helius Medical Technologies, Inc.
- Price $0.37
- Changes Percentage -20.4
- Change -0.0959
- Day Low $0.37
- Day High $0.49
- Year High $9.5
- Year Low $0.37
- Market Cap $1,337,856
- Price Avg 50 EMA (D) $0.71
- Price Avg 200 EMA (D) $3.19
- Exchange NASDAQ
- Volume 792,947
- Average Volume 239,409
- Open $0.48
- Previous Close $0.47
- EPS -9.7
- PE -0.04
- Earnings Announcement 2024-11-07 10:59:00
- Shares Outstanding $3,576,200
Company brief: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT )
- Healthcare
- Medical - Devices
- Mr. Dane Carl Andreeff
- https://heliusmedical.com
- US
- N/A
- 06-27-2014
- US42328V8019
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.